HU229454B1 - Antibodies capable to selectively detect prion prpsc isoforms - Google Patents

Antibodies capable to selectively detect prion prpsc isoforms

Info

Publication number
HU229454B1
HU229454B1 HU0302413A HUP0302413A HU229454B1 HU 229454 B1 HU229454 B1 HU 229454B1 HU 0302413 A HU0302413 A HU 0302413A HU P0302413 A HUP0302413 A HU P0302413A HU 229454 B1 HU229454 B1 HU 229454B1
Authority
HU
Hungary
Prior art keywords
antibodies capable
selectively detect
present
antibodies
detect prion
Prior art date
Application number
HU0302413A
Other languages
English (en)
Hungarian (hu)
Inventor
Vladka Curin-Serbec
Original Assignee
Blood Transfusion Ct Of Slovenia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8168816&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HU229454(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Blood Transfusion Ct Of Slovenia filed Critical Blood Transfusion Ct Of Slovenia
Publication of HUP0302413A2 publication Critical patent/HUP0302413A2/hu
Publication of HU229454B1 publication Critical patent/HU229454B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HU0302413A 2000-05-23 2001-05-15 Antibodies capable to selectively detect prion prpsc isoforms HU229454B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00111108A EP1158003B2 (en) 2000-05-23 2000-05-23 Antibodies capable to selectively detect prion PrP Sc isoforms
PCT/IB2001/001666 WO2001090191A2 (en) 2000-05-23 2001-05-15 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS

Publications (2)

Publication Number Publication Date
HUP0302413A2 HUP0302413A2 (hu) 2003-10-28
HU229454B1 true HU229454B1 (en) 2013-12-30

Family

ID=8168816

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302413A HU229454B1 (en) 2000-05-23 2001-05-15 Antibodies capable to selectively detect prion prpsc isoforms

Country Status (14)

Country Link
EP (1) EP1158003B2 (https=)
JP (1) JP5042430B2 (https=)
KR (1) KR100829447B1 (https=)
CN (1) CN1250572C (https=)
AR (1) AR029098A1 (https=)
AT (1) ATE312848T1 (https=)
AU (2) AU8435501A (https=)
CA (1) CA2407905C (https=)
DE (1) DE60024787T3 (https=)
DK (1) DK1158003T4 (https=)
ES (1) ES2253156T5 (https=)
HU (1) HU229454B1 (https=)
PL (1) PL208292B1 (https=)
WO (1) WO2001090191A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003205623A1 (en) * 2002-01-18 2003-07-30 Cytos Biotechnology Ag Prion protein carrier-conjugates
EP1596199A1 (en) * 2004-05-14 2005-11-16 Prionics AG Method for the detection of disease-related prion
JP4246777B1 (ja) * 2007-11-20 2009-04-02 森永乳業株式会社 異常型プリオン蛋白質結合剤および異常型プリオン蛋白質の検出方法
EP2135880A1 (en) * 2008-06-17 2009-12-23 Heinrich-Heine-Universität Düsseldorf Anti-prion protein antibody fragment
AU2009301580B2 (en) 2008-10-06 2015-11-26 The University Of British Columbia Methods and systems for predicting misfolded protein epitopes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE177754T1 (de) * 1991-12-03 1999-04-15 Proteus Molecular Design Fragmente von prion proteinen.
BR9610580A (pt) * 1995-09-14 2000-10-24 Univ California Anticorpos especìficos para prpse nativos
EP0861900A1 (en) † 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
DE19741607A1 (de) * 1997-09-20 1999-03-25 Prionics Ag Synthetische Polypeptide zur Diagnose und Therapie von Prionerkrankungen

Also Published As

Publication number Publication date
WO2001090191A2 (en) 2001-11-29
KR20030014234A (ko) 2003-02-15
JP5042430B2 (ja) 2012-10-03
DE60024787T2 (de) 2006-09-07
AU2001284355B2 (en) 2005-11-10
AR029098A1 (es) 2003-06-04
EP1158003B2 (en) 2012-12-26
ATE312848T1 (de) 2005-12-15
DE60024787D1 (de) 2006-01-19
HUP0302413A2 (hu) 2003-10-28
DK1158003T3 (da) 2006-05-01
CA2407905C (en) 2012-08-14
PL208292B1 (pl) 2011-04-29
WO2001090191A3 (en) 2002-06-20
DE60024787T3 (de) 2013-06-06
KR100829447B1 (ko) 2008-05-15
PL360139A1 (en) 2004-09-06
JP2003534000A (ja) 2003-11-18
AU8435501A (en) 2001-12-03
CN1250572C (zh) 2006-04-12
ES2253156T3 (es) 2006-06-01
CA2407905A1 (en) 2001-11-29
CN1441811A (zh) 2003-09-10
EP1158003B1 (en) 2005-12-14
DK1158003T4 (da) 2013-04-08
EP1158003A1 (en) 2001-11-28
ES2253156T5 (es) 2013-04-30

Similar Documents

Publication Publication Date Title
MX9802019A (es) Anticuerpos especificos para prpsc nativos.
Mangé et al. Alpha‐and beta‐cleavages of the amino‐terminus of the cellular prion protein
Bocharova et al. Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt‐Jakob Disease
Hooper Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein
US6765088B1 (en) Immunological detection of prions
Altmeppen et al. Proteolytic processing of the prion protein in health and disease
Demart et al. New insight into abnormal prion protein using monoclonal antibodies
Thompson et al. Amyloidogenicity and neurotoxicity of peptides corresponding to the helical regions of PrPC
Mishra et al. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders
Xiong et al. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein
Haigh et al. Copper binding is the governing determinant of prion protein turnover
Priola Prion protein and species barriers in the transmissible spongiform encephalopathies
Choi et al. Uptake and degradation of protease-sensitive and-resistant forms of abnormal human prion protein aggregates by human astrocytes
Sandmeier et al. Spontaneous deamidation and isomerization of Asn108 in prion peptide 106–126 and in full-length prion protein
HU229454B1 (en) Antibodies capable to selectively detect prion prpsc isoforms
Wong et al. Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR
Brini et al. The prion protein and its paralogue Doppel affect calcium signaling in Chinese hamster ovary cells
Kitamoto et al. N-terminal sequence of prion protein is also intergrated into kuru plaques in patients with Gerstmann-StraĘussler syndrome
AU2006204705B2 (en) ELISA assays using prion-specific peptide reagents
Thackray et al. Detection of bovine spongiform encephalopathy, ovine scrapie prion-related protein (PrPSc) and normal PrPc by monoclonal antibodies raised to copper-refolded prion protein
Rigter et al. Mapping of possible prion protein self-interaction domains using peptide arrays
Gao et al. Recombinant neural protein PrP can bind with both recombinant and native apolipoprotein E in vitro
Chen et al. Casein kinase II interacts with prion protein in vitro and forms complex with native prion protein in vivo
Gawinecka et al. Subtype-specific synaptic proteome alterations in sporadic Creutzfeldt-Jakob disease
WO2003050139A3 (en) Prion inhibiting peptides and derivatives thereof

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees